Page 35 - SFHN JAN 2022

35 January 2022 cannabisnewsflorida.com Cannabis News Florida

Visit us on the web at www.CannabisNewsFlorida.com
www.CannabisNewsFlorida.com

3rd party , independent testing researchers
are solely attributed to Dr. Jeff G. Konin.
continued product research performed by
that of Florida International University and
area of research that could be served well is
represented in this column do not reflect
Cannabinoid Research. It is a process. The
https://go.fiu.edu/GlobalCannabis. Views
Cannabis Research and Cannabis and
initiative you can visit their website at
are paying attention to the Journal of
research and education
journals like Addiction, and slowly more
To learn more about FIU’s cannabinoid
Nature as a few examples. Some do read

published: Plant Science, Molecules, or
Research and Education.
not read where these studies are being
Initiative for Cannabinoid
However, most healthcare providers do
University (FIU) where he directs the Global
27,000 published research articles.
Health Sciences at Florida International
using the word “cannabis” yields over
Nicole Wertheim College of Nursing and
National Library of Medicine search solely
the Department of Athletic Training in the
already exists. For example, a simple
Dr. Jeff G. Konin is a Clinical Professor in
fast-growing interest that ample research
could argue that in a relatively new area of

research will drive the rest!
relates to consumer benefits. In fact, some
apportion of acceptance and reputable
their own-house product research as it
many credible companies are performing
efficacy. Consumer demand will drive
nerships, sharing of findings, and product
in the cannabis space. In fact, as noted,
There is no shortage of business research
Cannabis research is ripe for ideas, part-
in reporting positive results.
possible.
highest and most professional manner
testing have a financially vested interested
flict of interest – that is, those doing the
ed and presented to all stakeholders in the
This is typically referred to having a con-
allows the findings of studies to be report-
but positive claims of one’s own product.
toward unbiased research. Doing so then
dence” will be expected to state nothing
study goals are all essential building blocks
published or even just self-promoted “evi-
ing funding amounts necessary to achieve
course not, so the expectation of any self-
solid strategic plan in place, and recogniz-
together on realistic timelines, having a
own product, and it wasn’t good? Of
pared for. Building teams and working
put out information that they tested their
it, have you ever seen a cannabis company
times one that private business is not pre-
ical and healthcare industry . Think about
pared for the many hurdles, and often-
University researchers excel in and are pre-
biased in opinion from those in the med-
own research will be viewed as being
ning to the end. The process is something
and any statements claimed from one’s
and it requires patience from the begin-
process. It takes time, it takes educating,
a consumer base. However, such findings
method of achieving this goal. It is a
able to stand behind a product and sell it to
research Universities is one reputable
essential step that needs to take place to be
uct. In fact, most would argue that it is an
industry . Private business partnering with
ures learned through marketing the prod-
it does make sense to test one’s own prod-
that is inclusive of all those vested in the
and disseminated through effective meas-
truly nothing wrong with this approach, as
cannabis research in a collaborative way
patients will only be successfully conveyed
This is an opportunistic time to define
majority have done so in-house. There is
a cannabinoid, the effective use for
conducted product efficacy research, the
that haven’t yet even been considered.
tion using a combination of or an isolate of
industry . Additionally , of those that have
drug interactions, and potentially findings
difference in favor of a positive interven-
or long-term adverse effects, unknown
expected in the medical and healthcare
ple, if medical researchers find a statistical
standings of any concerns related to short
previously described to the standards
research grounded in science. For exam-
ies without bias can produce true under-
actually conducted the clinical research
research grounded in business as well as
well-being of individuals. Likewise, stud-
facture and sell product to consumers have
a connection that should occur between
that cannabis intervention may play in the
ous cannabis-based businesses that manu-
questions is “yes” to both. There is clearly
than others. However, few of the numer-
future success of any efficacious findings
More than likely the answer to these
been positive, some finding greater success
address such concerns will be a key to the
cannabis-based research?
own internal research. The outcome has
flicts of interest. Identifying models that
approaches and perception of
worlds absent any perceived or real con-
cessful business practices based upon their
disconnect with such different
companies, many have in fact found suc-
connect remains that connects the two
Is there a connection or a
leading the way . Yet in other places, a dis-
tainly not the case with all cannabis-based

of what was just described. Though cer-
the way . In others, business research is
goals.
some places, scientific research is leading
date has found itself is the polar opposite
data in a way to meet business-related
Where the majority of the industry to
point toward its views of cannabis. In
process and/or approach and applies the
Society is at an international tipping
business perspective.
information. It simply involves a different
findings.
its potential from either a healthcare or a
way minimizes the importance of the
benefit from contemporary cannabis-based
al business-like manner, it will not reach
important as the bottom line. This in no
pediatrics, neurology and others would
ings, if this is not conveyed in a profession-
cases, statistics may or may not be as
uct appears to demonstrate positive find-
areas such a sports medicine, geriatrics,
market trends” just to name a few. In such
tion. In particular, journals of specialized
However, regardless of how good a prod-
mize sales and profits”, or “interpreting
and ongoing improvements and findings.
that focus and emphasize clinical applica-
an effort to “make wise decisions, “maxi-
uct, identifying price points and margins,
with results being published in journals
Continued from back cover
Back Cover: What Exactly is “Cannabis Research?”
TM
AROUND